{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T18:23:14Z","timestamp":1764094994933,"version":"3.45.0"},"reference-count":11,"publisher":"BMJ","funder":[{"name":"Health Education England\/NIHR","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Frontline Gastroenterol"],"accepted":{"date-parts":[[2025,11,4]]},"abstract":"<jats:p>This guideline review summarises the key recommendations for the diagnosis and management of ulcerative colitis from the updated 2025 British Society of Gastroenterology guidelines on inflammatory bowel disease in adults.<\/jats:p>","DOI":"10.1136\/flgastro-2025-103426","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T18:20:16Z","timestamp":1764094816000},"page":"flgastro-2025-103426","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["2025 British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: Part 2 \u2013 ulcerative colitis"],"prefix":"10.1136","clinical-trial-number":[{"clinical-trial-number":"nct04925973","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0918-6713","authenticated-orcid":false,"given":"Thomas D","family":"Butler","sequence":"first","affiliation":[{"name":"Division of Diabetes, Endocrinology and Gastroenterology, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK"},{"name":"Northern Care Alliance NHS Foundation Trust, Salford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Segal","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Royal Melbourne Hospital, Parkville, Victoria, Australia"},{"name":"Department of Medicine, University of Melbourne, Fitzroy, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"2025112510200950000_flgastro-2025-103426v1.1","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2024-334395","article-title":"British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025","volume":"74","author":"Moran","year":"2025","journal-title":"Gut"},{"key":"2025112510200950000_flgastro-2025-103426v1.2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2022-001067","article-title":"BSG 2024 IBD guidelines protocol (standard operating procedures)","volume":"10","author":"Gordon","year":"2023","journal-title":"BMJ Open Gastroenterol"},{"key":"2025112510200950000_flgastro-2025-103426v1.3","first-page":"1583","article-title":"A Core Outcome Set for Inflammatory Bowel Diseases: Development and Recommendations for Implementation in Clinical Practice Through an International Multi-stakeholder Consensus Process","volume":"18","author":"Fierens","year":"2024","journal-title":"Journal of Crohn\u2019s and Colitis"},{"key":"2025112510200950000_flgastro-2025-103426v1.4","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.12.031"},{"key":"2025112510200950000_flgastro-2025-103426v1.5","doi-asserted-by":"crossref","unstructured":"East JE , Gordon M , Nigam GB , et al . British Society of Gastroenterology guidelines on colorectal surveillance in inflammatory bowel disease. Gut 2025. doi:10.1136\/gutjnl-2025-335023","DOI":"10.1136\/gutjnl-2025-335023"},{"key":"2025112510200950000_flgastro-2025-103426v1.6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S2468-1253(21)00062-5","article-title":"Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial","volume":"6","author":"Kobayashi","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025112510200950000_flgastro-2025-103426v1.7","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.6.905"},{"key":"2025112510200950000_flgastro-2025-103426v1.8","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S2468-1253(24)00200-0","article-title":"Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial","volume":"9","author":"Choy","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025112510200950000_flgastro-2025-103426v1.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2208450"},{"key":"2025112510200950000_flgastro-2025-103426v1.10","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaa225"},{"key":"2025112510200950000_flgastro-2025-103426v1.11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2024.10.001"}],"container-title":["Frontline Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/flgastro-2025-103426","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T18:20:17Z","timestamp":1764094817000},"score":1,"resource":{"primary":{"URL":"https:\/\/fg.bmj.com\/lookup\/doi\/10.1136\/flgastro-2025-103426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":11,"alternative-id":["10.1136\/flgastro-2025-103426"],"URL":"https:\/\/doi.org\/10.1136\/flgastro-2025-103426","relation":{},"ISSN":["2041-4137","2041-4145"],"issn-type":[{"value":"2041-4137","type":"print"},{"value":"2041-4145","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]}}}